<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Respiratory Research - Latest articles</title>
		<link>http://respiratory-research.com</link>
		<description>The latest articles from Respiratory Research (ISSN 1465-9921) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://respiratory-research.com/content/9/1/68"/>			    
            
				    <rdf:li rdf:resource="http://respiratory-research.com/content/9/1/67"/>			    
            
				    <rdf:li rdf:resource="http://respiratory-research.com/content/9/1/66"/>			    
            
				    <rdf:li rdf:resource="http://respiratory-research.com/content/9/1/65"/>			    
            
				    <rdf:li rdf:resource="http://respiratory-research.com/content/9/1/64"/>			    
            
				    <rdf:li rdf:resource="http://respiratory-research.com/content/9/1/63"/>			    
            
				    <rdf:li rdf:resource="http://respiratory-research.com/content/9/1/62"/>			    
            
				    <rdf:li rdf:resource="http://respiratory-research.com/content/9/1/61"/>			    
            
				    <rdf:li rdf:resource="http://respiratory-research.com/content/9/1/60"/>			    
            
				    <rdf:li rdf:resource="http://respiratory-research.com/content/9/1/59"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://respiratory-research.com/content/9/1/68">
            
            <title>Membrane diffusion- and capillary blood volume measurements are not useful as screening tools for pulmonary arterial hypertension in systemic sclerosis: a case-control study</title>
			<description>Background:
There is no optimal screening tool for the assessment of pulmonary arterial hypertension (PAH) in patients with systemic sclerosis (SSc). A decreasing transfer factor of the lung for CO (TLCO) is associated with the development of PAH in SSc. TLCO can be partitioned into the diffusion of the alveolar capillary membrane (Dm) and the capillary blood volume (Vc). The use of the partitioned diffusion to detect PAH in SSc is not well established yet. This study evaluates whether Dm and Vc could be candidates for further study of the use for screening for PAH in SSc.
Methods:
Eleven SSc patients with PAH (SScPAH+), 13 SSc patients without PAH (SScPAH-) and 10 healthy control subjects were included. Pulmonary function testing took place at diagnosis of PAH. TLCO was partitioned according to Roughton and Forster. As pulmonary fibrosis in SSc influences values of the (partitioned) TLCO, these were adjusted for fibrosis score as assessed on HRCT.
Results:
TLCO as percentage of predicted (%) was lower in SScPAH+ than in SScPAH- (41+/-7% vs. 63+/-12%, p&lt;0.0001, respectively). Dm% in SScPAH+ was decreased as compared with SScPAH- (22+/-6% vs. 39+/-12%, p&lt;0.0001, respectively), also after adjustment for total fibrosis score (before adjustment: B = 17.5, 95% CI 9.0- 25.9, p = &lt; 0.0001; after adjustment: B = 14.3, 95% CI 6.0 -21.7, p= 0.008). No difference was found in Vc%. There were no correlations between pulmonary hemodynamic parameters and Dm% in the PAH groups.
Conclusion:
SScPAH+ patients have lower Dm% than SScPAH- patients. There are no correlations between Dm% and hemodynamic parameters of PAH in SScPAH+. These findings do not support further study of the role of partitioning TLCO in the diagnostic work up for PAH in SSc. </description>
			<link>http://respiratory-research.com/content/9/1/68</link>
			
			 	<dc:creator>Maria J Overbeek, Herman Groepenhoff, Alexandre E Voskuyl, Egbert F Smit, Jochem WL Peeters, Anton Vonk-Noordegraaf, Marieke D Spreeuwenberg, Ben C Dijkmans and Anco Boonstra</dc:creator>
			
			<dc:source>Respiratory Research 2008, 9:68</dc:source>
			<dc:date>2008-10-01</dc:date>
			<dc:identifier>doi:10.1186/1465-9921-9-68</dc:identifier>
			
			
							
					<prism:publicationName>Respiratory Research</prism:publicationName>
					
			
							
					<prism:issn>1465-9921</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>68</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-10-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://respiratory-research.com/content/9/1/67">
            
            <title>A multivariate analysis of serum nutrient levels and lung function</title>
			<description>Background:
There is mounting evidence that estimates of intakes of a range of dietary nutrients are related to both lung function level and rate of decline, but far less evidence on the relation between lung function and objective measures of serum levels of individual nutrients. The aim of this study was to conduct a comprehensive examination of the independent associations of a wide range of serum markers of nutritional status with lung function, measured as the one-second forced expiratory volume (FEV1).
Methods:
Using data from the Third National Health and Nutrition Examination Survey, a US population-based cross-sectional study, we investigated the relation between 21 serum markers of potentially relevant nutrients and FEV1, with adjustment for potential confounding factors. Systematic approaches were used to guide the analysis.
Results:
In a mutually adjusted model, higher serum levels of antioxidant vitamins (vitamin A, beta-cryptoxanthin, vitamin C, vitamin E), selenium, normalized calcium, chloride, and iron were independently associated with higher levels of FEV1. Higher concentrations of potassium and sodium were associated with lower FEV1.
Conclusion:
Maintaining higher serum concentrations of dietary antioxidant vitamins and selenium is potentially beneficial to lung health. In addition other novel associations found in this study merit further investigation.</description>
			<link>http://respiratory-research.com/content/9/1/67</link>
			
			 	<dc:creator>Tricia M McKeever, Sarah A Lewis, Henriette A Smit, Peter Burney, Patricia A Cassano and John Britton</dc:creator>
			
			<dc:source>Respiratory Research 2008, 9:67</dc:source>
			<dc:date>2008-09-29</dc:date>
			<dc:identifier>doi:10.1186/1465-9921-9-67</dc:identifier>
			
			
							
					<prism:publicationName>Respiratory Research</prism:publicationName>
					
			
							
					<prism:issn>1465-9921</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>67</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://respiratory-research.com/content/9/1/66">
            
            <title>NF-kappa B Mediates the Survival of Human Bronchial Epithelial Cells Exposed to Cigarette Smoke Extract</title>
			<description>Background:
We have previously reported that low concentrations of cigarette smoke extract induce DNA damage without leading to apoptosis or necrosis in human bronchial epithelial cells (HBECs), and that IL-6/STAT3 signaling contributes to the cell survival. Since NF-kappaB is also involved in regulating apoptosis and cell survival, the current study was designed to investigate the role of NF-kappaB in mediating cell survival in response to cigarette smoke exposure in HBECs.
Methods:
Both the pharmacologic inhibitor of NF-kappaB, curcumin, and RNA interference targeting p65 were used to block NF-kappaB signaling in HBECs. Apoptosis and cell survival were then assessed by various methods including COMET assay, LIVE/DEAD Cytotoxicity/Viability assay and colony formation assay. 
Results:
Cigarette smoke extract (CSE) caused DNA damage and cell cycle arrest in S phase without leading to apoptosis in HBECs as evidenced by TUNEL assay, COMET assay and DNA content assay. CSE stimulated NF-kappaB -DNA binding activity and up-regulated Bcl-XL protein in HBECs. Inhibition of NF-kappaB by the pharmacologic inhibitor curcumin (20uM) or suppression of p65 by siRNA resulted in a significant increase in cell death in response to cigarette smoke exposure. Furthermore, cells lacking p65 were incapable of forming cellular colonies when these cells were exposed to CSE, while they behaved normally in the regular culture medium. 
Conclusion:
The current study demonstrates that CSE activates NF-kappaB and up-regulates Bcl-XL through NF-kB activation in HBECs, and that CSE induces cell death in cells lacking p65. These results suggest that activation of NF-kappaB regulates cell survival following DNA damage by cigarette smoke in human bronchial epithelial cells.</description>
			<link>http://respiratory-research.com/content/9/1/66</link>
			
			 	<dc:creator>Xiangde Liu, Shinsaku Togo, Mona Al-Mugotir, Huijung Kim, QiuHong Fang, Tetsu Kobayashi, XingQi Wang, Lijun Mao, Peter Bitterman and Stephen Rennard</dc:creator>
			
			<dc:source>Respiratory Research 2008, 9:66</dc:source>
			<dc:date>2008-09-23</dc:date>
			<dc:identifier>doi:10.1186/1465-9921-9-66</dc:identifier>
			
			
							
					<prism:publicationName>Respiratory Research</prism:publicationName>
					
			
							
					<prism:issn>1465-9921</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>66</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-23</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://respiratory-research.com/content/9/1/65">
            
            <title>Role of viral hemagglutinin glycosylation in anti-influenza activities of recombinant surfactant protein D</title>
			<description>Background:
Surfactant protein D (SP-D) plays an important role in innate defense against influenza A viruses (IAVs) and other pathogens.
Methods:
We tested antiviral activities of recombinant human SP-D against a panel of IAV strains that vary in glycosylation sites on their hemagglutinin (HA). For these experiments a recombinant version of human SP-D of the Met11, Ala160 genotype was used after it was characterized biochemically and structurally.
Results:
Oligosaccharides at amino acid 165 on the HA in the H3N2 subtype and 104 in the H1N1 subtype are absent in collectin-resistant strains developed in vitro and are important for mediating antiviral activity of SP-D; however, other glycans on the HA of these viral subtypes also are involved in inhibition by SP-D. H3N2 strains obtained shortly after introduction into the human population were largely resistant to SP-D, despite having the glycan at 165. H3N2 strains have become steadily more sensitive to SP-D over time in the human population, in association with addition of other glycans to the head region of the HA. In contrast, H1N1 strains were most sensitive in the 1970s&#8211;1980s and more recent strains have become less sensitive, despite retaining the glycan at 104. Two H5N1 strains were also resistant to inhibition by SP-D. By comparing sites of glycan attachment on sensitive vs. resistant strains, specific glycan sites on the head domain of the HA are implicated as important for inhibition by SP-D. Molecular modeling of the glycan attachment sites on HA and the carbohydrate recognition domain of SPD are consistent with these observations.
Conclusion:
Inhibition by SP-D correlates with presence of several glycan attachment sites on the HA. Pandemic and avian strains appear to lack susceptibility to SP-D and this could be a contributory factor to their virulence.</description>
			<link>http://respiratory-research.com/content/9/1/65</link>
			
			 	<dc:creator>Kevan L Hartshorn, Richard Webby, Mitchell R White, Tesfaldet Tecle, Clark Pan, Susan Boucher, Rodney J Moreland, Erika C Crouch and Ronald K Scheule</dc:creator>
			
			<dc:source>Respiratory Research 2008, 9:65</dc:source>
			<dc:date>2008-09-23</dc:date>
			<dc:identifier>doi:10.1186/1465-9921-9-65</dc:identifier>
			
			
							
					<prism:publicationName>Respiratory Research</prism:publicationName>
					
			
							
					<prism:issn>1465-9921</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>65</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-23</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://respiratory-research.com/content/9/1/64">
            
            <title>Association of mast cells with lung function in chronic obstructive pulmonary disease</title>
			<description>Background:
In asthma, higher chymase positive mast cell (MC-C) numbers are associated with less airway obstruction. In COPD, the distribution of MC-C and tryptase positive mast cells (MC-T) in central and peripheral airways, and their relation with lung function, is unknown. We compared MC-T and MC-C distributions in COPD and controls without airflow limitation, and determined their relation with lung function.
Methods:
Lung tissue sections from 19 COPD patients (median [interquartile range] FEV1% predicted 56 [23&#8211;75]) and 10 controls were stained for tryptase and chymase. Numbers of MC-T and MC-C were determined in different regions of central and peripheral airways and percentage of degranulation was determined.
Results:
COPD patients had lower MC-T numbers in the subepithelial area of central airways than controls. In COPD, MC-T numbers in the airway wall and more specifically in the epithelium and subepithelial area of peripheral airways correlated positively with FEV1/VC (Spearman's rho (rs) 0.47, p = 0.05 and rs 0.48, p = 0.05, respectively); MC-C numbers in airway smooth muscle of peripheral airways correlated positively with FEV1% predicted (rs 0.57, p = 0.02). Both in COPD patients and controls the percentage of degranulated MC-T and MC-C mast cells was higher in peripheral than in central airways (all p &lt; 0.05), but this was not different between the groups.
Conclusion:
More MC-T and MC-C in peripheral airways correlate with better lung function in COPD patients. It is yet to determine whether this reflects a protective association of mast cells with COPD pathogenesis, or that other explanations are to be considered.</description>
			<link>http://respiratory-research.com/content/9/1/64</link>
			
			 	<dc:creator>Margot ME Gosman, Dirkje S Postma, Judith M Vonk, Bea Rutgers, Monique Lodewijk, Mieke Smith, Marjan A Luinge, Nick HT ten Hacken and Wim Timens</dc:creator>
			
			<dc:source>Respiratory Research 2008, 9:64</dc:source>
			<dc:date>2008-09-10</dc:date>
			<dc:identifier>doi:10.1186/1465-9921-9-64</dc:identifier>
			
			
							
					<prism:publicationName>Respiratory Research</prism:publicationName>
					
			
							
					<prism:issn>1465-9921</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>64</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://respiratory-research.com/content/9/1/63">
            
            <title>Early life environment and snoring in adulthood</title>
			<description>Background:
To our knowledge, no studies of the possible association of early life environment with snoring in adulthood have been published. We aimed to investigate whether early life environment is associated with snoring later in life.
Methods:
A questionnaire including snoring frequency in adulthood and environmental factors in early life was obtained from 16,190 randomly selected men and women, aged 25&#8211;54 years, in Sweden, Norway, Iceland, Denmark and Estonia (response rate 74%).
Results:
A total of 15,556 subjects answered the questions on snoring. Habitual snoring, defined as loud and disturbing snoring at least 3 nights a week, was reported by 18%. Being hospitalized for a respiratory infection before the age of two years (adjusted odds ratio (OR) = 1.27; 95% confidence interval (CI) 1.01&#8211;1.59), suffering from recurrent otitis as a child (OR = 1.18; 95%CI 1.05&#8211;1.33), growing up in a large family (OR = 1.04; 95%CI 1.002&#8211;1.07) and being exposed to a dog at home as a newborn (OR = 1.26; 95%CI 1.12&#8211;1.42) were independently related to snoring later in life and independent of a number of possible confounders in adulthood. The same childhood environmental factors except household size were also related with snoring and daytime sleepiness combined.
Conclusion:
The predisposition for adult snoring may be partly established early in life. Having had severe airway infections or recurrent otitis in childhood, being exposed to a dog as a newborn and growing up in a large family are environmental factors associated with snoring in adulthood.</description>
			<link>http://respiratory-research.com/content/9/1/63</link>
			
			 	<dc:creator>Karl A Franklin, Christer Janson, Th&#243;rarinn G&#237;slason, Amund Gulsvik, Maria Gunnbj&#246;rnsdottir, Birger N Laerum, Eva Lindberg, Eva Norrman, Lennarth Nystr&#246;m, Ernst Omenaas, Kjell Tor&#233;n and Cecilie Svanes</dc:creator>
			
			<dc:source>Respiratory Research 2008, 9:63</dc:source>
			<dc:date>2008-08-22</dc:date>
			<dc:identifier>doi:10.1186/1465-9921-9-63</dc:identifier>
			
			
							
					<prism:publicationName>Respiratory Research</prism:publicationName>
					
			
							
					<prism:issn>1465-9921</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>63</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://respiratory-research.com/content/9/1/62">
            
            <title>Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit</title>
			<description>Background:
Guidelines on COPD diagnosis and management encourage primary care physicians to detect the disease at an early stage and to treat patients according to their condition and needs. Problems in guideline implementation include difficulties in diagnosis, using spirometry and the disputed role of reversibility testing. These lead to inaccurate diagnostic registers and inadequacy of administered treatments. This study represents an audit of COPD diagnosis and management in primary care practices in Devon.
Methods:
Six hundred and thirty two patients on COPD registers in primary care practices were seen by a visiting Respiratory Specialist Nurse. Diagnoses were made according to the NICE guidelines. Reversibility testing was carried out either routinely or based on clinical indication in two sub-samples. Dyspnoea was assessed. Data were entered into a novel IT-based software which computed guideline-based treatment recommendations. Current and recommended treatments were compared.
Results:
Five hundred and eighty patients had spirometry. Diagnoses of COPD were confirmed in 422 patients (73%). Thirty nine patients were identified as asthma only, 94 had normal spirometry, 23 were restrictive and 2 had a cardiac disorder. Reversibility testing changed diagnosis of 11% of patients with airflow obstruction, and severity grading in 18%. Three quarters of patients with COPD had been offered practical help with smoking cessation. Short and long-acting anticholinergics and long acting beta-2 agonists had been under-prescribed; in 15&#8211;18% of patients they were indicated but not received. Inhaled steroids had been over-prescribed (recommended in 17%; taken by 60%), whereas only 4% of patients with a chronic productive cough were receiving mucolytics. Pulmonary rehabilitation was not available in some areas and was under-used in other areas.
Conclusion:
Diagnostic registers of COPD in primary care contain mistakes leading to inaccurate prevalence estimates and inappropriate treatment decisions. Use of pre-bronchodilator readings for diagnosis overestimates the prevalence and severity in a significant minority, thus post bronchodilator readings should be used. Management of stable COPD does often not correspond to guidelines. The IT system used in this study has the potential to improve diagnosis and management of COPD in primary care.</description>
			<link>http://respiratory-research.com/content/9/1/62</link>
			
			 	<dc:creator>Rupert CM Jones, Maria Dickson-Spillmann, Martin JC Mather, Dawn Marks and Bryanie S Shackell</dc:creator>
			
			<dc:source>Respiratory Research 2008, 9:62</dc:source>
			<dc:date>2008-08-18</dc:date>
			<dc:identifier>doi:10.1186/1465-9921-9-62</dc:identifier>
			
			
							
					<prism:publicationName>Respiratory Research</prism:publicationName>
					
			
							
					<prism:issn>1465-9921</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>62</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-18</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://respiratory-research.com/content/9/1/61">
            
            <title>Time course of airway remodelling after an acute chlorine gas exposure in mice</title>
			<description>Accidental chlorine (Cl2) gas inhalation is a common cause of acute airway injury. However, little is known about the kinetics of airway injury and repair after Cl2 exposure. We investigated the time course of airway epithelial damage and repair in mice after a single exposure to a high concentration of Cl2 gas. Mice were exposed to 800 ppm Cl2 gas for 5 minutes and studied from 12 hrs to 10 days post-exposure. The acute injury phase after Cl2 exposure (&#8804; 24 hrs post-exposure) was characterized by airway epithelial cell apoptosis (increased TUNEL staining) and sloughing, elevated protein in bronchoalveolar lavage fluid, and a modest increase in airway responses to methacholine. The repair phase after Cl2 exposure was characterized by increased airway epithelial cell proliferation, measured by immunoreactive proliferating cell nuclear antigen (PCNA), with maximal proliferation occurring 5 days after Cl2 exposure. At 10 days after Cl2 exposure the airway smooth muscle mass was increased relative to controls, suggestive of airway smooth muscle hyperplasia and there was evidence of airway fibrosis. No increase in goblet cells occurred at any time point. We conclude that a single exposure of mice to Cl2 gas causes acute changes in lung function, including pulmonary responsiveness to methacholine challenge, associated with airway damage, followed by subsequent repair and airway remodelling.</description>
			<link>http://respiratory-research.com/content/9/1/61</link>
			
			 	<dc:creator>Stephanie A Tuck, David Ramos-Barb&#243;n, Holly Campbell, Toby McGovern, Harry Karmouty-Quintana and James G Martin</dc:creator>
			
			<dc:source>Respiratory Research 2008, 9:61</dc:source>
			<dc:date>2008-08-14</dc:date>
			<dc:identifier>doi:10.1186/1465-9921-9-61</dc:identifier>
			
			
							
					<prism:publicationName>Respiratory Research</prism:publicationName>
					
			
							
					<prism:issn>1465-9921</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>61</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://respiratory-research.com/content/9/1/60">
            
            <title>Neutrophil elastase reduces secretion of secretory leukoproteinase inhibitor (SLPI) by lung epithelial cells: role of charge of the proteinase-inhibitor complex</title>
			<description>Background:
Secretory leukoproteinase inhibitor (SLPI) is an important inhibitor of neutrophil elastase (NE), a proteinase implicated in the pathogenesis of lung diseases such as COPD. SLPI also has antimicrobial and anti-inflammatory properties, but the concentration of SLPI in lung secretions in COPD varies inversely with infection and the concentration of NE. A fall in SLPI concentration is also seen in culture supernatants of respiratory cells exposed to NE, for unknown reasons. We investigated the hypothesis that SLPI complexed with NE associates with cell membranes in vitro.
Methods:
Respiratory epithelial cells were cultured in the presence of SLPI, varying doses of proteinases over time, and in different experimental conditions. The likely predicted charge of the complex between SLPI and proteinases was assessed by theoretical molecular modelling.
Results:
We observed a rapid, linear decrease in SLPI concentration in culture supernatants with increasing concentration of NE and cathepsin G, but not with other serine proteinases. The effect of NE was inhibited fully by a synthetic NE inhibitor only when added at the same time as NE. Direct contact between NE and SLPI was required for a fall in SLPI concentration. Passive binding to cell culture plate materials was able to remove a substantial amount of SLPI both with and without NE. Theoretical molecular modelling of the structure of SLPI in complex with various proteinases showed a greater positive charge for the complex with NE and cathepsin G than for other proteinases, such as trypsin and mast cell tryptase, that also bind SLPI but without reducing its concentration.
Conclusion:
These data suggest that NE-mediated decrease in SLPI is a passive, charge-dependent phenomenon in vitro, which may correlate with changes observed in vivo.</description>
			<link>http://respiratory-research.com/content/9/1/60</link>
			
			 	<dc:creator>Anita L Sullivan, Timothy Dafforn, Pieter S Hiemstra and Robert A Stockley</dc:creator>
			
			<dc:source>Respiratory Research 2008, 9:60</dc:source>
			<dc:date>2008-08-12</dc:date>
			<dc:identifier>doi:10.1186/1465-9921-9-60</dc:identifier>
			
			
							
					<prism:publicationName>Respiratory Research</prism:publicationName>
					
			
							
					<prism:issn>1465-9921</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>60</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://respiratory-research.com/content/9/1/59">
            
            <title>Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry</title>
			<description>Background:
Scavenger receptors are important components of the innate immune system in the lung, allowing alveolar macrophages to bind and phagocytose numerous unopsonized targets. Mice with genetic deletions of scavenger receptors, such as SR-A and MARCO, are susceptible to infection or inflammation from inhaled pathogens or dusts. However, the signaling pathways required for scavenger receptor-mediated phagocytosis of unopsonized particles have not been characterized.
Methods:
We developed a scanning cytometry-based high-throughput assay of macrophage phagocytosis that quantitates bound and internalized unopsonized latex beads. This assay allowed the testing of a panel of signaling inhibitors which have previously been shown to target opsonin-dependent phagocytosis for their effect on unopsonized bead uptake by human in vitro-derived alveolar macrophage-like cells. The non-selective scavenger receptor inhibitor poly(I) and the actin destabilizer cytochalasin D were used to validate the assay and caused near complete abrogation of bead binding and internalization, respectively.
Results:
Microtubule destabilization using nocodazole dramatically inhibited bead internalization. Internalization was also significantly reduced by inhibitors of tyrosine kinases (genistein and herbimycin A), protein kinase C (staurosporine, chelerythrine chloride and G&#246; 6976), phosphoinositide-3 kinase (LY294002 and wortmannin), and the JNK and ERK pathways. In contrast, inhibition of phospholipase C by U-73122 had no effect.
Conclusion:
These data indicate the utility of scanning cytometry for the analysis of phagocytosis and that phagocytosis of unopsonized particles has both shared and distinct features when compared to opsonin-mediated phagocytosis.</description>
			<link>http://respiratory-research.com/content/9/1/59</link>
			
			 	<dc:creator>Timothy H Sulahian, Amy Imrich, Glen DeLoid, Aaron R Winkler and Lester Kobzik</dc:creator>
			
			<dc:source>Respiratory Research 2008, 9:59</dc:source>
			<dc:date>2008-08-07</dc:date>
			<dc:identifier>doi:10.1186/1465-9921-9-59</dc:identifier>
			
			
							
					<prism:publicationName>Respiratory Research</prism:publicationName>
					
			
							
					<prism:issn>1465-9921</prism:issn>
					
			
							
					<prism:volume>9</prism:volume>
					
			
							
					<prism:startingPage>59</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-07</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
